• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝病患者的肠道通透性和细菌易位,重点关注酒精性病因:评估方法和治疗干预

Intestinal permeability and bacterial translocation in patients with liver disease, focusing on alcoholic aetiology: methods of assessment and therapeutic intervention.

作者信息

Skinner Charlotte, Thompson Alex J, Thursz Mark R, Marchesi Julian R, Vergis Nikhil

机构信息

Department of Metabolism, Digestion and Reproduction, St Mary's Hospital Campus, Imperial College London, London, UK.

Department of Surgery & Cancer, St. Mary's Hospital Campus, Imperial College London, London, UK.

出版信息

Therap Adv Gastroenterol. 2020 Oct 16;13:1756284820942616. doi: 10.1177/1756284820942616. eCollection 2020.

DOI:10.1177/1756284820942616
PMID:33149761
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7580143/
Abstract

Increased bacterial translocation (BT) across the gut barrier due to greater intestinal permeability (IP) is seen across a range of conditions, including alcohol-related liver disease (ArLD). The phenomenon of BT may contribute to both the pathogenesis and the development of complications in ArLD. There are a number of methods available to assess IP and in this review we look at their various advantages and limitations. The knowledge around BT and IP in ArLD is also reviewed, as well as the therapeutic strategies currently in use and in development.

摘要

在包括酒精性肝病(ArLD)在内的一系列病症中,均可观察到由于肠道通透性(IP)增加导致细菌易位(BT)穿过肠道屏障的现象。BT现象可能在ArLD的发病机制和并发症发展中都起作用。有多种方法可用于评估IP,在本综述中,我们将探讨它们的各种优缺点。同时还将综述有关ArLD中BT和IP的知识,以及目前正在使用和研发的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e7/7580143/0a0628d8c93f/10.1177_1756284820942616-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e7/7580143/a5d20cf835b3/10.1177_1756284820942616-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e7/7580143/0a0628d8c93f/10.1177_1756284820942616-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e7/7580143/a5d20cf835b3/10.1177_1756284820942616-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e7/7580143/0a0628d8c93f/10.1177_1756284820942616-fig2.jpg

相似文献

1
Intestinal permeability and bacterial translocation in patients with liver disease, focusing on alcoholic aetiology: methods of assessment and therapeutic intervention.肝病患者的肠道通透性和细菌易位,重点关注酒精性病因:评估方法和治疗干预
Therap Adv Gastroenterol. 2020 Oct 16;13:1756284820942616. doi: 10.1177/1756284820942616. eCollection 2020.
2
Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut-Vascular Barrier Damage Across Stages of Cirrhosis.肝硬化各阶段肠道通透性、细菌移位和肠-血管屏障损伤的替代标志物
Liver Int. 2025 Jun;45(6):e70119. doi: 10.1111/liv.70119.
3
Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.肠道通透性在肝损伤发病机制中的作用:从非酒精性脂肪性肝病到肝移植。
World J Gastroenterol. 2019 Sep 7;25(33):4814-4834. doi: 10.3748/wjg.v25.i33.4814.
4
Alcoholic liver disease: the gut microbiome and liver cross talk.酒精性肝病:肠道微生物群与肝脏的相互作用
Alcohol Clin Exp Res. 2015 May;39(5):763-75. doi: 10.1111/acer.12704.
5
Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.青蒿琥酯补充剂对肝硬化大鼠肠道细菌易位和肠道微生物群失调的影响。
World J Gastroenterol. 2016 Mar 14;22(10):2949-59. doi: 10.3748/wjg.v22.i10.2949.
6
Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.肠通透性、微生物易位、十二指肠和粪便微生物群的变化及其与人类酒精性肝病进展的关系。
Gut Microbes. 2020 Nov 9;12(1):1782157. doi: 10.1080/19490976.2020.1782157. Epub 2020 Jun 26.
7
FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.FXR 通过调节实验性肝硬化中细菌易位的进入部位来调节肠道-血管屏障。
J Hepatol. 2019 Dec;71(6):1126-1140. doi: 10.1016/j.jhep.2019.06.017. Epub 2019 Jul 8.
8
Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis.西沙必利对肝硬化患者肠道细菌及内毒素移位的影响。
World J Gastroenterol. 2003 Mar;9(3):534-8. doi: 10.3748/wjg.v9.i3.534.
9
Bacterial translocation (BT) in cirrhosis.肝硬化中的细菌易位(BT)
Hepatology. 2005 Mar;41(3):422-33. doi: 10.1002/hep.20632.
10
Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease.与酒精性肝病相关的细菌易位及肠道微生物群的变化。
World J Hepatol. 2012 Apr 27;4(4):110-8. doi: 10.4254/wjh.v4.i4.110.

引用本文的文献

1
Analysis of gut and circulating microbiota characteristics in patients with liver cirrhosis and portal vein thrombosis.肝硬化合并门静脉血栓形成患者肠道及循环微生物群特征分析
Front Microbiol. 2025 Jun 19;16:1597145. doi: 10.3389/fmicb.2025.1597145. eCollection 2025.
2
Serum zonulin and colorectal cancer risk.血清肠通透素与结直肠癌风险。
Sci Rep. 2024 Nov 15;14(1):28171. doi: 10.1038/s41598-024-76697-z.
3
Elevated intestinal fatty acid-binding protein levels as a marker of portal hypertension and gastroesophageal varices in cirrhosis.

本文引用的文献

1
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease.噬菌体靶向肠道细菌可减轻酒精性肝病。
Nature. 2019 Nov;575(7783):505-511. doi: 10.1038/s41586-019-1742-x. Epub 2019 Nov 13.
2
Intestinal injury and gut permeability in sickle cell disease.镰状细胞病中的肠损伤和肠道通透性。
J Transl Med. 2019 May 30;17(1):183. doi: 10.1186/s12967-019-1938-8.
3
PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial.
血清肠脂肪酸结合蛋白水平升高可作为肝硬化门静脉高压和胃食管静脉曲张的标志物。
Sci Rep. 2024 Oct 23;14(1):25003. doi: 10.1038/s41598-024-76040-6.
4
Diabetes mellitus and the risk of spontaneous bacterial peritonitis in patients with liver cirrhosis: a systematic review and meta-analysis.糖尿病与肝硬化患者自发性细菌性腹膜炎风险的关系:系统评价和荟萃分析。
Ann Saudi Med. 2024 Jul-Aug;44(4):272-287. doi: 10.5144/0256-4947.2024.272. Epub 2024 Aug 1.
5
Serum bile acids profiles are altered without change of the gut microbiota composition following a seven-day prednisolone therapy in severe alcoholic hepatitis.血清胆汁酸谱在严重酒精性肝炎患者七天泼尼松龙治疗后发生改变,而肠道微生物组成没有变化。
Gut Microbes. 2024 Jan-Dec;16(1):2382767. doi: 10.1080/19490976.2024.2382767. Epub 2024 Jul 30.
6
Transcutaneous fluorescence spectroscopy: development and characterization of a compact, portable, and fiber-optic sensor.经皮荧光光谱法:一种紧凑、便携、光纤传感器的研发与特性描述。
J Biomed Opt. 2024 Feb;29(2):027003. doi: 10.1117/1.JBO.29.2.027003. Epub 2024 Feb 28.
7
Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis.肠道微生物群和细菌易位在肝纤维化发病机制中的作用。
Int J Mol Sci. 2023 Nov 19;24(22):16502. doi: 10.3390/ijms242216502.
8
The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status.慢性肝病发展过程中的肠道微生物群:现状
Diagnostics (Basel). 2023 Sep 15;13(18):2960. doi: 10.3390/diagnostics13182960.
9
Kidney disease in patients with chronic liver disease: Does sex matter?慢性肝病患者的肾脏疾病:性别有影响吗?
World J Clin Cases. 2023 Jun 16;11(17):3980-3992. doi: 10.12998/wjcc.v11.i17.3980.
10
Intestinal microbiota in the treatment of metabolically associated fatty liver disease.肠道微生物群在代谢相关脂肪性肝病治疗中的作用
World J Clin Cases. 2022 Nov 6;10(31):11240-11251. doi: 10.12998/wjcc.v10.i31.11240.
PROFIT:一项前瞻性、随机、安慰剂对照的粪便微生物群移植治疗肝硬化的可行性试验:一项单盲试验的研究方案。
BMJ Open. 2019 Feb 15;9(2):e023518. doi: 10.1136/bmjopen-2018-023518.
4
Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems.血清亲环素作为肠黏膜屏障功能的标志物:可能并非如其表面所示。
PLoS One. 2019 Jan 14;14(1):e0210728. doi: 10.1371/journal.pone.0210728. eCollection 2019.
5
The diagnosis of small intestinal bacterial overgrowth: Two steps forward, one step backwards?小肠细菌过度生长的诊断:两步前进,一步后退?
Neurogastroenterol Motil. 2018 Nov;30(11):e13494. doi: 10.1111/nmo.13494.
6
Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.肝硬化患者小肠细菌过度生长:系统评价和荟萃分析。
Hepatol Int. 2018 Nov;12(6):567-576. doi: 10.1007/s12072-018-9898-2. Epub 2018 Oct 4.
7
Burden of liver diseases in the world.世界范围内的肝脏疾病负担。
J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26.
8
Serum zonulin in patients with inflammatory bowel disease: a pilot study.炎症性肠病患者血清 zonulin:一项初步研究。
Minerva Med. 2019 Apr;110(2):95-100. doi: 10.23736/S0026-4806.18.05787-7. Epub 2018 Aug 28.
9
Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant.肝硬化中抗生素相关的微生物群落组成和功能紊乱可通过粪便移植恢复。
Hepatology. 2018 Oct;68(4):1549-1558. doi: 10.1002/hep.30037. Epub 2018 Sep 20.
10
Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.肠道菌群失调与通透性:在酒精依赖和酒精性肝病中的阴阳关系。
Clin Sci (Lond). 2018 Jan 19;132(2):199-212. doi: 10.1042/CS20171055. Print 2018 Jan 31.